With the rapid adoption of cloud computing, learn how Thermo Scientific™ Chromeleon™ CDS supports moving from a traditional on-premise setup to a cloud based deployment and associated benefits and challenges.
White Papers
08 March 2018
12 February 2018
21 CFR Part 11 requires Food and Drug Administration (FDA)-regulated industries, including medical device manufacturers, drug makers, biotech companies and biologics developers, to have validation documentation and implement controls such as audit trails and electronic signatures
31 January 2018
R&D-driven industries talk a lot about progressing towards the paperless laboratory. The ultimate aim is to capture and store all experimental, process, inventory and results data, from the earliest stages of discovery, through to manufacturing, QA/QC and even instrument management, in an electronic format
03 August 2017
Data governance is an integral part of a regulated company’s quality system. Having a chromatography data system can simplify system administration and ensure regulatory compliance (including 21 CFR Part 11) and adherence to data integrity guidelines.
08 June 2017
Audit trails are considered the key to the security of a system since they track changes to data and metadata. In this way, an incomplete or absent audit trail can impact data integrity or even product quality. The absence of an audit trail is considered to be, “highly significant when there are data discrepancies” according to the FDA.
Pages
Latest issue
Elsevier and ExactCure recently announced a collaboration to develop and offer to hospitals – without charge – drug-specific exposure models for 20 already approved medicines that are being tested as potential treatments for Covid-19.
With the world’s focus on the COVID-19 pandemic, LIMS providers are working to develop solutions tailored to assist in the testing and management of virus samples.
Researchers at Harvard Medical School (HMS) have released an open source drug discovery platform, VirtualFlow, that harnesses supercomputing power to screen potentially billions of small organic compound structures in parallel, in the hunt for promising new drug molecules.
When designing a component or system, where do you start? In days gone by, designers would literally go back to the drawing board, using their experience and expertise to develop a new concept.
Effective utilisation of computing tools is critical to both AI and HPC research, with recent projects in both fields highlighting the scientific benefit of carefully managing resources.
Advances in computer vision combined with AI computing are helping pathologists to more accurately identify subtypes of cancer - leading to better treatments for patients, explains Dan Ruderman.
